Immune to addiction: The ethical dimensions of vaccines against substance abuse

Nature Immunology

Volumn 13, Issue 6, 2012, Pages 521-524

  Young, Michael J ^a   Sisti, Dominic A ^b   Rimon Greenspan, Hila ^b   Schwartz, Jason L ^b   Caplan, Arthur L ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN B SUBUNIT; COCAINE; COCAINE DEPENDENCE VACCINE; COCAINE DERIVATIVE; ILLICIT DRUG; SUCCINYLNORCOCAINE; UNCLASSIFIED DRUG; VACCINE;

CLINICAL TRIAL (TOPIC); COCAINE DEPENDENCE; DRUG DEPENDENCE; DRUG SAFETY; DRUG SEEKING BEHAVIOR; ETHICS; FOOD AND DRUG ADMINISTRATION; HERD IMMUNITY; HIGH RISK POPULATION; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOTHERAPY; LEGAL ASPECT; MEDICAL DECISION MAKING; NONHUMAN; OFF LABEL DRUG USE; PATIENT AUTONOMY; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT; SOCIAL STIGMA; SUBSTANCE ABUSE; VACCINATION;

BEHAVIOR, ADDICTIVE; COCAINE-RELATED DISORDERS; HUMANS; VACCINATION; VACCINES;

EID: 84862077622     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2321     Document Type: Review

References (25)

1. Orson, F.M. et al. Ann. NY Acad. Sci. 1141, 257-269 (2008).
2. U.S. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration, "Drug Abuse Warning Network, 2009: National Estimates of Drug-Related Emergency Department Visits." HHS Publication (SMA ) 11-4659, DAWN Series D-35 (Substance Abuse and Mental Health Services Administration, Rockville, Maryland, 2011).
3. Volkow, N.D. & Skolnick, P. Neuropsychopharmacology 37, 290-292 (2012).
4. O'Brien, M.S. & Anthony, J.C. Neuropsychopharmacology 30, 1006-1018 (2005).
5. Haney, M., Gunderson, E.W., Jiang, H., Collins, E.D. & Foltin, R.W. Biol. Psychiatry 67, 59-65 (2010).
6. M artell, B.A. et al. Arch. Gen. Psychiatry 66, 1116-1123 (2009).
7. C arrera, M.R. et al. Nature 378, 727-730 (1995).
8. Stevenson, D. Rutgers J. L. & Urb. Pol'y 3, 4, n. 170 (2005).
9. E rsche, K.D. et al. Science 335, 601-604 (2012).
10. Hyman, S.E. Am. J. Bioeth. 7, 8-11 (2007).
11. Osburn, A. Cleveland State Law Rev. 55, 159-188 (2008).
12. A shcroft, R.E. & Franey, C. J. Med. Ethics 30, 341-343 (2004).
13. Friedman, H., Pross, S. & Klein, T.W. Fems. Immunol. Med. Microbiol. 47, 330-342 (2006).
14. C hristakis, N.A. & Fowler, J.H. Connected: The Surprising Power of Our Social Networks and How They Shape Our Lives, 1st edn. (Little, Brown and Co./Hachette Book Group, New York, 2009).
15. C aplan, A. Addiction 103, 1919-1921 (2008).
16. Y affe, G. Philos. Public Aff. 30, 178-221 (2001).
17. Hall, W. & Carter, L. J. Med. Ethics 30, 337-340 (2004).
18. Hasman, A. & Holm, S. J. Med. Ethics 30, 344-345 (2004).
19. C aplan, A. in Human Enhancement (eds. Savelescu, J. & Bostrum, N.) 199-210 (Oxford University Press, Oxford, 2009).
20. N ewman, P.A., Daley, A., Halpenny, R. & Loutfy, M. Vaccine 26, 1091-1097 (2008).
21. N ewman, P.A., Duan, N., Kakinami, L. & Roberts, K. Vaccine 26, 2528-2536 (2008).
22. Kosten, T. & Owens, S.M. Pharmacol. Ther. 108, 76-85 (2005).
23. Kosten, T.R. et al. Vaccine 20, 1196-1204 (2002).
24. Buka, S.L. Public Health Rep. 117, S118-S125 (2002).
25. Francis, A. Sociol. Health. Illn. 20, 1-16 (2012).